NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 82 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 179.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $22,000 | +37.5% | 157,306 | +0.1% | 0.00% | – |
| Q4 2018 | $16,000 | -55.6% | 157,090 | 0.0% | 0.00% | – |
| Q3 2018 | $36,000 | 0.0% | 157,090 | -0.0% | 0.00% | – |
| Q2 2018 | $36,000 | -40.0% | 157,102 | -5.9% | 0.00% | – |
| Q1 2018 | $60,000 | +1.7% | 166,868 | +0.7% | 0.00% | – |
| Q4 2017 | $59,000 | -21.3% | 165,699 | -8.5% | 0.00% | – |
| Q3 2017 | $75,000 | -16.7% | 181,164 | +2.6% | 0.00% | – |
| Q2 2017 | $90,000 | -55.9% | 176,631 | -49.7% | 0.00% | – |
| Q1 2017 | $204,000 | -8.1% | 351,120 | +1.0% | 0.00% | – |
| Q4 2016 | $222,000 | +44.2% | 347,564 | +106.8% | 0.00% | – |
| Q3 2016 | $154,000 | +67.4% | 168,101 | -3.1% | 0.00% | – |
| Q2 2016 | $92,000 | -51.8% | 173,551 | -14.1% | 0.00% | – |
| Q1 2016 | $191,000 | -39.2% | 202,149 | -14.2% | 0.00% | – |
| Q4 2015 | $314,000 | -34.0% | 235,706 | +12.9% | 0.00% | – |
| Q3 2015 | $476,000 | +59.7% | 208,752 | +12.7% | 0.00% | – |
| Q2 2015 | $298,000 | -2.3% | 185,257 | -3.5% | 0.00% | – |
| Q1 2015 | $305,000 | -35.8% | 192,042 | -23.6% | 0.00% | – |
| Q4 2014 | $475,000 | +37.7% | 251,518 | -3.7% | 0.00% | – |
| Q3 2014 | $345,000 | +3.6% | 261,193 | +16.2% | 0.00% | – |
| Q2 2014 | $333,000 | -19.2% | 224,713 | +0.9% | 0.00% | – |
| Q1 2014 | $412,000 | +4.0% | 222,769 | +16.6% | 0.00% | – |
| Q4 2013 | $396,000 | -24.3% | 191,015 | -3.3% | 0.00% | – |
| Q3 2013 | $523,000 | -15.5% | 197,435 | -14.9% | 0.00% | – |
| Q2 2013 | $619,000 | – | 231,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|